18261678

Source:http://linkedlifedata.com/resource/pubmed/id/18261678

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038257, umls-concept:C0087111, umls-concept:C1707455
pubmed:issue	6
pubmed:dateCreated	2008-2-11
pubmed:abstractText	The aim was to compare 2-year outcomes with the routine use of drug-eluting stents (DES) (>75% "off-label") with a comparable group treated with bare-metal stents (BMS).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18261678-18261679
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Hirudins, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/bivalirudin
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1558-3597
pubmed:author	pubmed-author:ApplegateRobert JRJ, pubmed-author:BakiTalal TTT, pubmed-author:GandhiSanjay KSK, pubmed-author:KutcherMichael AMA, pubmed-author:LittleWilliam CWC, pubmed-author:SacrintyMatthew TMT, pubmed-author:SantosRenato MRM
pubmed:issnType	Electronic
pubmed:day	12
pubmed:volume	51
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	607-14
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18261678-Angioplasty, Balloon, Coronary, pubmed-meshheading:18261678-Anticoagulants, pubmed-meshheading:18261678-Blood Vessel Prosthesis Implantation, pubmed-meshheading:18261678-Coronary Restenosis, pubmed-meshheading:18261678-Coronary Thrombosis, pubmed-meshheading:18261678-Drug-Eluting Stents, pubmed-meshheading:18261678-Female, pubmed-meshheading:18261678-Heparin, pubmed-meshheading:18261678-Hirudins, pubmed-meshheading:18261678-Humans, pubmed-meshheading:18261678-Immunosuppressive Agents, pubmed-meshheading:18261678-Male, pubmed-meshheading:18261678-Middle Aged, pubmed-meshheading:18261678-Myocardial Infarction, pubmed-meshheading:18261678-Paclitaxel, pubmed-meshheading:18261678-Peptide Fragments, pubmed-meshheading:18261678-Proportional Hazards Models, pubmed-meshheading:18261678-Recombinant Proteins, pubmed-meshheading:18261678-Recurrence, pubmed-meshheading:18261678-Risk Factors, pubmed-meshheading:18261678-Sirolimus, pubmed-meshheading:18261678-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.
pubmed:affiliation	Section of Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1045, USA. bapplega@wfubmc.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't